SCHEMBL242507

SCHEMBL242507

[NH]C(=O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL207960 0.72
Hydrochloric Acid SCHEMBL28480538 0.70
Glycine SCHEMBL391786 0.67 GLRA1 (1.00)
SCHEMBL5106 0.67
Glycine SCHEMBL3640989 0.67 GLRA1 (1.00)
SCHEMBL62594 0.67
Aminomethylamide SCHEMBL8299 0.67
Bicarbonate SCHEMBL2427929 0.67
Aminomethylamide SCHEMBL1354065 0.67 OR51E2 (0.54)
Glycine SCHEMBL6163 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1388 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4392032-A1 MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR FOR THE TREATMENT OR PREVENTION OF RENAL CYSTIC DISEASE AND CARDIORENAL SYNDROME Arena Pharmaceuticals, Inc. (US) 2024-07-03 EP claimed
CN-118063384-A Aromatic ring substituted pyrazole derivative and application thereof 四川农业大学 2024-05-24 CN claimed
US-11987588-B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2024-05-21 US claimed
US-20240140935-A1 NON-COVALENT DIMER CATION, SALT THEREOF, PREPARATION METHOD THEREOF, AND USE THEREOF AS ANTIOXIDANT SUZHOU PROTONATION CHAIN BIOTECHNOLOGY CO., LTD. (CN) 2024-05-02 US claimed
CN-117820232-A Non-covalent dimer cations, salts thereof, preparation method thereof and antioxidation application thereof 苏州质子链生物技术有限公司 2024-04-05 CN claimed
WO-2024067560-A1 SULFONAMIDE COMPOUND AND MEDICAL USE THEREOF 中国药科大学 2024-04-04 WO claimed
CN-117682973-A Sulfonamide compound and medical application thereof 中国药科大学 2024-03-12 CN claimed
US-20230219973-A1 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF MOLECURE S.A. (PL) 2023-07-13 US claimed
WO-2023119233-A1 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF MOLECURE S.A. (PL) 2023-06-29 WO claimed
EP-3720858-B1 MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO ARENA PHARM INC (US) 2023-06-07 EP claimed
EP-0003455-B1 3-AMINO-CARDENOLIDES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM ETABLISSEMENTS NATIVELLE S.A. (FR) 1985-04-17 EP claimed
US-4500526-A ANTIBIOTICS, BACTERICIDES BRISTOL-MYERS COMPANY (US) 1985-02-19 US claimed
US-4496560-A ACTIVE AGAINST GRAMPOSITIVE BACTERIA RHONE-POULENC SANTE (FR) 1985-01-29 US claimed
US-4493831-A ANTIBIOTICS, VIRICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-01-15 US claimed
EP-0107850-A1 Aminoglycoside derivatives, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-05-09 EP claimed
US-4250304-A ANTIBIOTICS ABBOTT LABORATORIES (US) 1981-02-10 US claimed
EP-0005507-A1 Process for the fragmentation of 3-(2-hydroxyimino-acetylamino)-2-oxo azetidin compounds and compounds obtained thereby CIBA-GEIGY AG (CH) 1979-11-28 EP claimed
US-4174312-A ACYLATION, HYDROLYSIS, SALT FORMATION, CATALYTIC HYDROGENATION ABBOTT LABORATORIES (US) 1979-11-13 US claimed
EP-0003455-A1 3-Amino-cardenolides, process for their preparation and medicines containing them ETABLISSEMENTS NATIVELLE S.A. (FR) 1979-08-08 EP claimed
US-4012379-A 7-Acetoacetamidocephem compounds TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1977-03-15 US claimed